China News Service, November 17th. According to foreign media reports, a new analysis shows that the combined profit of the new crown vaccine of Pfizer, BioNTech, and Modena is an average of 65,000 US dollars per minute; however, the world’s poorest countries Most of the population has not yet been vaccinated.

On December 14, 2020 local time, a nurse at the Jewish Medical Center in Long Island, New York demonstrated the first batch of new coronavirus vaccines in the United States.

On the same day, Pfizer's first batch of nearly 3 million doses of the new crown vaccine arrived in the United States.

Photo by China News Agency reporter Liao Pan

  The non-profit organization "People's Vaccine Alliance" based on the analysis and estimation of the income reports of these three drug dealers shows that their total pre-tax profit this year can reach 34 billion U.S. dollars, which is equivalent to earning more than 1,000 U.S. dollars per second and 65,000 per minute. US dollars or 93.5 million US dollars per day.

  The "People's Vaccine Alliance" also stated that these three companies sold most of their vaccines to rich countries, but left low-income countries in trouble.

  The alliance called on pharmaceutical companies to join the "Trade-related Intellectual Property Agreement" proposed by the World Trade Organization, and temporarily exempt the new crown vaccine patent rights to increase vaccine production and help poor countries obtain vaccines faster.

  Seyoum, the representative of the African branch of the People’s Vaccine Alliance, said: “Pfizer, BioNTech and Modena have used their monopoly advantages to prioritize the most profitable contracts they have signed with the richest governments, but ignore poor countries. "

  The alliance pointed out that the vaccine delivered by Pfizer-BioNTech to low-income countries accounted for less than 1% of its total supply, and Modena was even less at 0.2%.

Currently, 98% of people in low-income countries have not yet completed the vaccination.